|
|
|
|
|
|
-
推薦指數:
|
- 內容介紹
|
Consultative Hemostasis and Thrombosis, 2nd Edition
By Craig S. Kitchens, MD, Barbara M. Alving, MD and Craig M. Kessler, MD
Approx. 800 pages Approx. 700 illustrations
Trim size 8 1/2 X 11 in
Copyright 2007
Description
Effectively and efficiently diagnose and manage today's full range of clotting and bleeding disorders using clinical case studies that demonstrate real-world problems and solutions! For each condition examined, you’ll review concise descriptions of its associated symptoms, along with laboratory findings, diagnosis, differential diagnosis, and treatment – all the clinical guidance you need – at your fingertips. It’s the ideal real-life reference tool for busy physicians!
Key Features
A reader-friendly design, coupled with nearly 385 illustrations and at-a-glance tables – many new to this edition – equip you to quickly locate the guidance you need.
Abundant laboratory protocols enable you to select and interpret lab tests more easily.
New to this Edition
A complete section on women’s health issues helps you stay current in this evolving area.
A new chapter on the impact of herbal medicines examines their effect on hemostasis and their interaction with other drugs.
New coverage of hemostatic issues in traumatology, sepsis, interventional radiology, pulmonology, and cardiology allows you to master the latest advances.
Table of Contents
Part I: General Information
CHAPTER 1: The Consultative Process Craig S. Kitchens, MD
CHAPTER 2: A Systematic Approach to the Bleeding Patient: Correlation of Clinical Symptoms and Signs with Laboratory Testing Craig Kessler, MD Nushmia Khokhar, MD Minetta Liu, MD
CHAPTER 3: Endothelium William C. Aird, MD
Part II: Hemorrhagic Processes
CHAPTER 4: Hemophilia A and B Lisa N. Boggio, MS, MD Craig M. Kessler, MD
CHAPTER 5: Less Common Congenital Disorders of Hemostasis Harold R. Roberts, MD Miguel A. Escobar, MD
CHAPTER 6: Non-hemophilic inhibitors of coagulation Bruce Ewenstein, MD, PhD
CHAPTER 7: von Willebrand Disease Margaret E. Rick, MD
CHAPTER 8: General aspects of thrombocytopenia, platelet transfusions and platelet growth factors David Kuter, MD
CHAPTER 9: Immune Thrombocytopenic Purpura James N. George, MD Kiarash Kojouri, MD
CHAPTER 10:Congenital and Acquired Disorders of Platelet Function and Number Shawn Jobe, MD, PhD Jorge Di Paola, MD
CHAPTER 11: Purpura and Other Hematovascular Disoders Marc Zumberg, MD Craig S. Kitchens, MD
CHAPTER 12: Disseminated Intravascular Coagulation Carrie LaBelle, MD Craig S. Kitchens, MD
CHAPTER 13: The cross-talk of inflammation and coagulation in infectious disease and their value in disseminated intravascular coagulation Eefje Jong, MD Eric C.M. van Gorp, MD Marcel Levi, MD Hugo ten Cate, MD
Part III: Thrombotic Processes
CHAPTER 14: Thrombophilia: Clinical and Laboratory Assessment and Management John A. Heit, MD
CHAPTER 15: Deep Vein Thrombosis and Pulmonary Embolism Samuel Z. Goldhaber, MD
CHAPTER 16: Venous Thromboses at Unusual Sites Marc S. Zumberg MD Craig S. Kitchens, MD
CHAPTER 17: Prevention, Diagnosis, and Treatment of the Postphlebitic Syndrome Reagan W. Quan, MD David L. Gillespie, MD
CHAPTER 18: Thrombocytosis: essential thrombocythemia vs. reactive etiologies Craig M. Kessler, MD Jan Jacques Michiels, MD, PhD
CHAPTER 19: The Antiphospholipid Syndrome: Clinical Presentation, Diagnosis, and Patient Management Jacob Rand, MD Miles B. Levin, MD Barbara M. Alving MD
CHAPTER 20: Hemostatic aspects of cardiovascular medicine Richard C. Becker, MD
CHAPTER 21: Risk factors for arterial thrombosis Mary Cushman, MD, MSc Barbara M. Alving, MD
CHAPTER 22: Peripheral Arterial Disease William R. Hiatt, MD
CHAPTER 23: Thrombosis and Cancer Frederick R. Rickles, MD, FACP Mark Levine, MD, MSc
CHAPTER 24: Thrombotic Thrombocytopenic Purpura Joel L. Moake, MD
CHAPTER 25: Heparin-Induced Thrombocytopenia Theodore E. Warkentin, MD
Part IV: Therapeutic Measures
CHAPTER 26: Antithrombotic Agents Charles W. Francis, MD
CHAPTER 27: Blood Component And Pharmacologic Therapy of Hemostatic Disorders Charles D. Bolan, MD Harvey G. Klein, MD
CHAPTER 28 : Thrombolytic Therapy Victor J. Marder, MD
CHAPTER 29: Topical Hemostatic Agents for Localized Bleeding Mark R. Jackson, MD
CHAPTER 30: Therapeutic Apheresis Chelsea A. Sheppard, MD Christopher D. Hillyer, MD
CHAPTER 31: Vena Cava Filters Christine L. Hann, MD Michael B. Streiff, MD
CHAPTER 32: Thrombosis Related to Venous Access Devices McDonald K. Horne III, MD Richard Chang, MD
CHAPTER 33: Dietary Supplements and Hemostasis Teirona Low Dog, MD Merry-Jennifer Markham, MD
Part V: Issues Specific to Women
CHAPTER 34: Thrombotic Risk of Contraceptives and Other Hormonal Therapies Suman Sood, MD Steven Stein, MD Barbara A. Konkle, MD
CHAPTER 35: Management of Bleeding Disorders in Pregnancy Stephanie Seremetis, MD Victoria Afshani, MD
CHAPTER 36: Management of thrombophilia and APLS during pregnancy Jody L. Kujovich, MD Barbara M. Alving, MD
Part VI: Special Issues
CHAPTER 37: Surgery and Hemostasis Craig S. Kitchens, MD
CHAPTER 38: Anticoagulation in the Perioperative Period Bundarika Suwanawiboon, MD Thomas L. Ortel, MD, PhD
CHAPTER 39: Hemostasis Alterations in Liver Disease and Liver Transplantation M. Senzolo, MD AK Burroughs, MD
CHAPTER 40: Outpatient Anticoagulant Therapy Jack E. Ansell, MD
CHAPTER 41: Point of Care Testing for Hemostatic Disorders Kendra Kubiak, MD B. Gail Macik, MD
CHAPTER 42: Prevention and Treatment of Venous Thromboembolism in Neurologic and Neurosurgical Patients David Green, MD, PhD
CHAPTER 43: Hematologic Interventions for Acute Central Nervous System Disease Fred Rincon, MD Andres Fernandez, MD Stephan A. Mayer, MD
CHAPTER 44: Atrial Septal Abnormalities and Cryptogenic Stroke Peter C. Block, MD
CHAPTER 45: Pulmonary Hypertension: Thrombotic and Non-Thrombotic in Origin Lewis J. Rubin, MD
CHAPTER 46:Hemorrhage Control and Thrombosis Following Severe Injury Ann B. Zimrin, MD John B. Holcomb, MD John R. Hess, MD
CHAPTER 47:Hemostatic Aspects of Sickle Cell Disease Kenneth Ataga, MD Richard Lottenberg, MD
CHAPTER 48: Anticoagulation for Atrial Fibrillation and Prosthetic Cardiac Valves Thomas G. DeLoughery, MD
|
|
|